Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Yves Vanrenterghem
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Chemicals & Drugs
Physiology
Concepts & Ideas
Disorders
Anatomy
Living Beings
Sign-in to see full Profile
Network (preview)
65
Evenepoel, Pieter
44
Kuypers, Dirk
43
Maes, Bart
42
Kuypers, Dirk
35
Claes, Kathleen
30
Waer, Mark
29
Roels, Leo
27
Bammens, Bert
22
Coosemans, Willy
21
Verbeke, Kristin
19
Naesens, Maarten
18
Maes, Bart
16
Van Damme, Boudewijn
15
Vanwalleghem, Johan
15
Lerut, Evelyne
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Yves Vanrenterghem (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Naesens Maarten; Lerut Evelyne; de Jonge Hylke; Van Damme Boudewijn; Vanrenterghem Yves; Kuypers Dirk R J
Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.
Journal of the American Society of Nephrology : JASN 2009;20(11):2468-80.
-
2009: Evenepoel P; Lerut E; Naesens M; Bammens B; Claes K; Kuypers D; Vermeersch P; Meijers B; Van Damme B; Vanrenterghem Y
Localization, etiology and impact of calcium phosphate deposits in renal allografts.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(11):2470-8.
-
2009: Meijers Björn K I; Van Kerckhoven Soetkin; Verbeke Kristin; Dehaen Wim; Vanrenterghem Yves; Hoylaerts Marc F; Evenepoel Pieter
The uremic retention solute p-cresyl sulfate and markers of endothelial damage.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(5):891-901.
-
2009: Naesens M; Lerut E; Sarwal M; Van Damme B; Vanrenterghem Y; Kuypers D R J
Balancing efficacy and toxicity of kidney transplant immunosuppression.
Transplantation proceedings 2009;41(8):3393-5.
-
2009: Meier-Kriesche Herwig-Ulf; Schold Jesse D; Vanrenterghem Yves; Halloran Philip F; Ekberg Henrik
Uric acid levels have no significant effect on renal function in adult renal transplant recipients: evidence from the symphony study.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(10):1655-60.
-
2009: Ekberg H; Bernasconi C; Tedesco-Silva H; Vítko S; Hugo C; Demirbas A; Acevedo R Reyes; Grinyó J; Frei U; Vanrenterghem Y; Daloze P; Halloran P
Calcineurin inhibitor minimization in the symphony study: observational results 3 years after transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(8):1876-85.
-
2009: Scharpé Johan; Peetermans Willy E; Vanwalleghem Johan; Maes Bart; Bammens Bert; Claes Kathleen; Osterhaus André D; Vanrenterghem Yves; Evenepoel Pieter
Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(1):77-85.
-
2009: Vanrenterghem Yves
Comment on "Volume of patients from the West of Scotland traveling to Pakistan for living donor kidney transplants".
Transplantation 2009;87(11):1749; author reply 1749-50.
-
2009: Vanrenterghem Yves
Anemia after kidney transplantation.
Transplantation 2009;87(9):1265-7.
-
2009: Evenepoel Pieter; Van Den Bergh Barbara; Naesens Maarten; De Jonge Hylke; Bammens Bert; Claes Kathleen; Kuypers Dirk; Vanrenterghem Yves
Calcium metabolism in the early posttransplantation period.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(3):665-72.
-
2009: Gillard Pieter; Vandemeulebroucke Evy; Keymeulen Bart; Pirenne Jacques; Maes Bart; De Pauw Pieter; Vanrenterghem Yves; Pipeleers Daniel; Mathieu Chantal
Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients.
Transplantation 2009;87(3):402-7.
-
2009: Kuypers Dirk R J; Bammens Bert; Claes Kathleen; Evenepoel Pieter; Lerut Evelyne; Vanrenterghem Yves
A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
The Journal of antimicrobial chemotherapy 2009;63(2):417-9.
-
2008: Evenepoel Pieter; Meijers Bjorn K I; de Jonge Hylke; Naesens Maarten; Bammens Bert; Claes Kathleen; Kuypers Dirk; Vanrenterghem Yves
Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(6):1829-36.
-
2008: Kuypers Dirk R; de Jonge Hylke; Naesens Maarten; Vanrenterghem Yves
Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients.
Pharmacogenetics and genomics 2008;18(10):861-8.
-
2008: Cornelis Tom; Bammens Bert; Lerut Evelyne; Cosyn Luc; Goovaerts Gerda; Westhovens René; Vanrenterghem Yves
AA amyloidosis due to chronic oxalate arthritis and vasculitis in a patient with secondary oxalosis after jejunoileal bypass surgery.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(10):3362-4.
-
2008: Grinyó Josep; Vanrenterghem Yves; Nashan Björn; Vincenti Flavio; Ekberg Henrik; Lindpaintner Klaus; Rashford Michelle; Nasmyth-Miller Clare; Voulgari Athina; Spleiss Olivia; Truman Matthew; Essioux Laurent
Association of four DNA polymorphisms with acute rejection after kidney transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2008;21(9):879-91.
-
2008: Fieuws Steffen; Verbeke Geert; Maes Bart; Vanrenterghem Yves
Predicting renal graft failure using multivariate longitudinal profiles.
Biostatistics (Oxford, England) 2008;9(3):419-31.
-
2008: Kubasiewicz L; Maleux G; Oyen R; Vanrenterghem Y; Kuypers D R J
Pseudoaneurysm complicating protocol renal transplant biopsies: case reports.
Transplantation proceedings 2008;40(5):1397-8.
-
2008: Kuypers Dirk R J; Claes Kathleen; Bammens Bert; Evenepoel Pieter; Vanrenterghem Yves
Early clinical assessment of glucose metabolism in renal allograft recipients: diagnosis and prediction of post-transplant diabetes mellitus (PTDM).
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(6):2033-42.
-
2008: Rizopoulos Dimitris; Verbeke Geert; Lesaffre Emmanuel; Vanrenterghem Yves
A two-part joint model for the analysis of survival and longitudinal binary data with excess zeros.
Biometrics 2008;64(2):611-9.
-
2008: Meijers B K I; Bammens B; De Moor B; Verbeke K; Vanrenterghem Y; Evenepoel P
Free p-cresol is associated with cardiovascular disease in hemodialysis patients.
Kidney international 2008;73(10):1174-80.
-
2008: Kuypers Dirk R J; de Jonge Hylke; Naesens Maarten; de Loor Henriette; Halewijck Evelyne; Dekens Marc; Vanrenterghem Yves
Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients.
Clinical therapeutics 2008;30(4):673-83.
-
2008: de Loor Henriette; Naesens Maarten; Verbeke Kristin; Vanrenterghem Yves; Kuypers Dirk R
Stability of mycophenolic acid and glucuronide metabolites in human plasma and the impact of deproteinization methodology.
Clinica chimica acta; international journal of clinical chemistry 2008;389(1-2):87-92.
-
2008: Scharpé J; Evenepoel P; Maes B; Bammens B; Claes K; Osterhaus A D; Vanrenterghem Y; Peetermans W E
Influenza vaccination is efficacious and safe in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(2):332-7.
-
2008: Sprangers B; Smets S; Sagaert X; Wozniak A; Wollants E; Van Ranst M; Debiec-Rychter M; Sciot R; Vanrenterghem Y; Kuypers D R
Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008;8(1):253-8.
-
2008: Claes K; Bammens B; Delforge M; Evenepoel P; Kuypers D; Vanrenterghem Y
Another devastating complication of the Schnitzler syndrome: AA amyloidosis.
The British journal of dermatology 2008;158(1):182-4.
-
2008: de Jonge Hylke; Vanrenterghem Yves
Aristolochic acid: the common culprit of Chinese herbs nephropathy and Balkan endemic nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2008;23(1):39-41.
-
2008: Viaene Liesbeth; Evenepoel Pieter; Bammens Bert; Claes Kathleen; Kuypers Dirk; Vanrenterghem Yves
Calcium requirements after parathyroidectomy in patients with refractory secondary hyperparathyroidism.
Nephron. Clinical practice 2008;110(2):c80-5.
-
2007: Ekberg Henrik; Tedesco-Silva Helio; Demirbas Alper; Vítko Stefan; Nashan Björn; Gürkan Alp; Margreiter Raimund; Hugo Christian; Grinyó Josep M; Frei Ulrich; Vanrenterghem Yves; Daloze Pierre; Halloran Philip F;
Reduced exposure to calcineurin inhibitors in renal transplantation.
The New England journal of medicine 2007;357(25):2562-75.
-
2007: Kuypers D R J; de Jonge H; Naesens M; Lerut E; Verbeke K; Vanrenterghem Y
CYP3A5 and CYP3A4 but not MDR1 single-nucleotide polymorphisms determine long-term tacrolimus disposition and drug-related nephrotoxicity in renal recipients.
Clinical pharmacology and therapeutics 2007;82(6):711-25.
-
2007: Meijers B K I; Verhamme P; Nevens F; Hoylaerts M F; Bammens B; Wilmer A; Arnout J; Vanrenterghem Y; Evenepoel P
Major coagulation disturbances during fractionated plasma separation and adsorption.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(9):2195-9.
-
2007: Naesens M; Lerut E; Damme B V; Vanrenterghem Y; Kuypers D R J
Tacrolimus exposure and evolution of renal allograft histology in the first year after transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(9):2114-23.
-
2007: Naesens Maarten; de Loor Henriette; Vanrenterghem Yves; Kuypers Dirk R J
The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
Transplantation 2007;84(3):362-73.
-
2007: Lerut Evelyne; Naesens Maarten; Kuypers Dirk R; Vanrenterghem Yves; Van Damme Boudewijn
Subclinical peritubular capillaritis at 3 months is associated with chronic rejection at 1 year.
Transplantation 2007;83(11):1416-22.
-
2007: Evenepoel Pieter; Claes Kathleen; Kuypers Dirk R; Debruyne Frans; Vanrenterghem Yves
Parathyroidectomy after successful kidney transplantation: a single centre study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(6):1730-7.
-
2007: Lerut Evelyne; Kuypers Dirk R; Verbeken Erik; Cleutjens Jack; Vlaminck Hans; Vanrenterghem Yves; Van Damme Boudewijn
Acute rejection in non-compliant renal allograft recipients: a distinct morphology.
Clinical transplantation 2007;21(3):344-51.
-
2007: Evenepoel Pieter; Dejagere Tom; Verhamme Peter; Claes Kathleen; Kuypers Dirk; Bammens Bert; Vanrenterghem Yves
Heparin-coated polyacrylonitrile membrane versus regional citrate anticoagulation: a prospective randomized study of 2 anticoagulation strategies in patients at risk of bleeding.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(5):642-9.
-
2007: Evenepoel P; Naesens M; Claes K; Kuypers D; Vanrenterghem Y
Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(5):1193-200.
-
2007: Naesens Maarten; Verbeke Kristin; Vanrenterghem Yves; Kuypers Dirk
Effects of gastric emptying on oral mycophenolic acid pharmacokinetics in stable renal allograft recipients.
British journal of clinical pharmacology 2007;63(5):541-7.
-
2007: Kuypers Dirk R J; Lerut Evelyne; Claes Kathleen; Evenepoel Pieter; Vanrenterghem Yves
Recurrence of light chain deposit disease after renal allograft transplantation: potential role of rituximab?
Transplant international : official journal of the European Society for Organ Transplantation 2007;20(4):381-5.
-
2007: Ekberg H; Grinyó J; Nashan B; Vanrenterghem Y; Vincenti F; Voulgari A; Truman M; Nasmyth-Miller C; Rashford M
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2007;7(3):560-70.
-
2007: Lerut Evelyne; Van Damme Boudewijn; Noizat-Pirenne France; Emonds Marie-Paule; Rouger Philippe; Vanrenterghem Yves; Pirenne Jacques; Ansart-Pirenne Hélène
Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection?
Transfusion 2007;47(1):28-40.
-
2006: Sprangers Ben; Evenepoel Pieter; Vanrenterghem Yves
Late referral of patients with chronic kidney disease: no time to waste.
Mayo Clinic proceedings. Mayo Clinic 2006;81(11):1487-94.
-
2006: Naesens Maarten; Kuypers Dirk R J; Streit Frank; Armstrong Victor W; Oellerich Michael; Verbeke Kristin; Vanrenterghem Yves
Rifampin induces alterations in mycophenolic acid glucuronidation and elimination: implications for drug exposure in renal allograft recipients.
Clinical pharmacology and therapeutics 2006;80(5):509-21.
-
2006: Dyckmans Kristine; Lerut Evelyne; Gillard Pieter; Lannoo Matthias; Ectors Nadine; Hoorens Anne; Mathieu Chantal; Coosemans Willy; Vanrenterghem Yves; Kuypers Dirk
Post-transplant lymphoma of the pancreatic allograft in a kidney-pancreas transplant recipient: a misleading presentation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(11):3306-10.
-
2006: Naesens Maarten; Kuypers Dirk R J; Verbeke Kristin; Vanrenterghem Yves
Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients.
Transplantation 2006;82(8):1074-84.
-
2006: Denhaerynck Kris; Desmyttere Ariane; Dobbels Fabienne; Moons Philip; Young Jim; Siegal Bonita; Greenstein Stuart; Steiger Jürg; Vanrenterghem Yves; Squifflet Jean-Paul; van Hooff Johannes P; De Geest Sabina
Nonadherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipients.
Progress in transplantation (Aliso Viejo, Calif.) 2006;16(3):206-14.
-
2006: Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Superior dialytic clearance of beta(2)-microglobulin and p-cresol by high-flux hemodialysis as compared to peritoneal dialysis.
Kidney international 2006;70(4):794-9.
-
2006: Evenepoel P; Bammens B; Verbeke K; Vanrenterghem Y
Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study.
Kidney international 2006;70(1):192-8.
-
2006: Kuypers Dirk R; Claes Kathleen; Evenepoel Pieter; Vanrenterghem Yves
Clinically relevant drug interaction between voriconazole and tacrolimus in a primary renal allograft recipient.
Transplantation 2006;81(12):1750-2.
-
2006: de Jonge Hylke; Bammens Bert; Lemahieu Wim; Maes Bart D; Vanrenterghem Yves
Comparison of peritoneal dialysis and haemodialysis after renal transplant failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2006;21(6):1669-74.
-
2006: Evenepoel Pieter; Laleman Wim; Wilmer Alexander; Claes Kathleen; Kuypers Dirk; Bammens Bert; Nevens Frederik; Vanrenterghem Yves
Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.
Artificial organs 2006;30(4):276-84.
-
2006: Bammens B; Evenepoel P; Keuleers H; Verbeke K; Vanrenterghem Y
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients.
Kidney international 2006;69(6):1081-7.
-
2006: Meylaerts L; Ooms V; Lyra S; Claes K; Vanrenterghem Y; Demaerel Ph
Hypertensive brain stem encephalopathy in a patient with chronic renal failure.
Clinical nephrology 2006;65(2):138-40.
-
2005: Ooms Vanessa; Decupere Marc; Lerut Evelyne; Vanrenterghem Yves; Kuypers Dirk R J
Secondary renal amyloidosis due to long-standing tubulointerstitial nephritis in a patient with Sjögren syndrome.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(5):e75-80.
-
2005: Kuypers Dirk R J; Naesens Maarten; Vermeire Severine; Vanrenterghem Yves
The impact of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients.
Clinical pharmacology and therapeutics 2005;78(4):351-61.
-
2005: Bammens Bert; Evenepoel Pieter; Verbeke Kristin; Vanrenterghem Yves
Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;46(3):512-9.
-
2005: Lemahieu W P D; Hermann M; Asberg A; Verbeke K; Holdaas H; Vanrenterghem Y; Maes B D
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(9):2236-43.
-
2005: Abramowicz Daniel; Vanrenterghem Yves; Squifflet Jean-Paul; Kuypers Dirk; Mourad Michel; Meurisse Michel; Wissing Martin
Efficacy and cardiovascular safety of daclizumab, mycophenolate mofetil, tacrolimus, and early steroid withdrawal in renal transplant recipients: a multicenter, prospective, pilot trial.
Clinical transplantation 2005;19(4):475-82.
-
2005: Kuypers Dirk R J; Vandooren Ann-Karolien; Lerut Evelyne; Evenepoel Pieter; Claes Kathleen; Snoeck Robert; Naesens Lieve; Vanrenterghem Yves
Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(8):1997-2004.
-
2005: Evenepoel Pieter; Claes Kathleen; Kuypers Dirk; Maes Bart; Vanrenterghem Yves
Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(8):1714-20.
-
2005: Malaise J; Kuypers D R J; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y; Van Ophem D; Squifflet J P;
Immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Transplantation proceedings 2005;37(6):2840-2.
-
2005: Kuypers Dirk R J; Verleden Geert; Naesens Maarten; Vanrenterghem Yves
Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase.
Clinical pharmacology and therapeutics 2005;78(1):81-8.
-
2005: Evenepoel Pieter; Bammens Bert; Nevens Frederik; Wilmer Alexander; Vanrenterghem Yves
The molecular adsorbent recycling system (MARS) and transmembrane transport of albumin-bound toxins.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2005;11(7):853-4; author reply 855.
-
2005: Lemahieu W P D; Maes B D; Vanrenterghem Y
Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine.
Transplantation proceedings 2005;37(5):2051-3.
-
2005: Tedesco-Silva Helio; Mourad Georges; Kahan Barry D; Boira Josep Grinyo; Weimar Willem; Mulgaonkar Shamkant; Nashan Björn; Madsen Soren; Charpentier Bernard; Pellet Pascale; Vanrenterghem Yves
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Transplantation 2005;79(11):1553-60.
-
2005: Lemahieu Wim; Maes Bart; Verbeke Kristin; Rutgeerts Paul; Geboes Karel; Vanrenterghem Yves
Cytochrome P450 3A4 and P-glycoprotein activity and assimilation of tacrolimus in transplant patients with persistent diarrhea.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(6):1383-91.
-
2005: Vandecasteele Stefaan J; Maes Bart; Claes Kathleen; Sciot Raf; Vanrenterghem Yves
High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(6):1246-7.
-
2005: Hörl Walter H; Vanrenterghem Yves; Canaud Bernard; Mann Johannes; Teatini Ugo; Wanner Christoph; Wikström Björn
Optimal treatment of renal anaemia (OPTA): improving the efficacy and efficiency of renal anaemia therapy in haemodialysis patients receiving intravenous epoetin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20 Suppl 3():iii25-32.
-
2005: Kuypers Dirk R J; Malaise Jacques; Claes Kathleen; Evenepoel Pieter; Maes Bart; Coosemans Willy; Pirenne Jacques; Vanrenterghem Yves;
Secondary effects of immunosuppressive drugs after simultaneous pancreas-kidney transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20 Suppl 2():ii33-9, ii62.
-
2005: Kuypers Dirk R; Claes Katleen; Evenepoel Pieter; Maes Bart; Vandecasteele Stefaan; Vanrenterghem Yves; Van Damme Boudewijn; Desmet Koenraad
Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient.
Transplantation 2005;79(6):737.
-
2005: Kuypers Dirk R J; Claes Kathleen; Evenepoel Pieter; Maes Bart; Vanrenterghem Yves
A simplified strategy for clinical management of late cytomegalovirus infection after oral ganciclovir prophylaxis in renal recipients.
The Journal of antimicrobial chemotherapy 2005;55(3):391-4.
-
2005: Lemahieu Wim P D; Maes Bart D; Verbeke Kristin; Vanrenterghem Yves
Impact of gastric acid suppressants on cytochrome P450 3A4 and P-glycoprotein: consequences for FK506 assimilation.
Kidney international 2005;67(3):1152-60.
-
2005: Dejagere Tom; Evenepoel Pieter; Claes Kathleen; Kuypers Dirk; Maes Bart; Vanrenterghem Yves
Acute-onset, steroid-sensitive, encapsulating peritoneal sclerosis in a renal transplant recipient.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(2):e33-7.
-
2005: Vanrenterghem Yves; van Hooff Johannes P; Squifflet Jean-Paul; Salmela Kaija; Rigotti Paolo; Jindal Rahul M; Pascual Julio; Ekberg Henrik; Sicilia Luis Sanchez; Boletis John N; Grinyo Josep M; Rodriguez Manuel Arias;
Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(1):87-95.
-
2005: Cohen Bernard; Smits Jacqueline M; Haase Bernadette; Persijn Guido; Vanrenterghem Yves; Frei Ulrich
Expanding the donor pool to increase renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(1):34-41.
-
2005: Evenepoel Pieter; Laleman Wim; Wilmer Alexander; Claes Kathleen; Maes Bart; Kuypers Dirk; Bammens Bert; Nevens Frederik; Vanrenterghem Yves
Detoxifying capacity and kinetics of prometheus--a new extracorporeal system for the treatment of liver failure.
Blood purification 2005;23(5):349-58.
-
2005: Meeus Gert; Kuypers Dirk R J; Claes Kathleen; Evenepoel Pieter; Maes Bart; Vanrenterghem Yves
A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
Blood purification 2005;23(2):101-5.
-
2004: Bammens Bert; Evenepoel Pieter; Verbeke Kristin; Vanrenterghem Yves
Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept.
The American journal of clinical nutrition 2004;80(6):1536-43.
-
2004: Maes Bart; Vanrenterghem Yves
MYSS: should we alter clinical practice?
Lancet 2004;364(9450):2016-7; author reply 2017-8.
-
2004: Vanrenterghem Yves
Post-transplant diabetes mellitus and renal function with tacrolimus: A decade of use, a decade of evidence. Foreword.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 6():vi1-vi2.
-
2004: Kuypers Dirk R J; Claes Kathleen; Evenepoel P; Maes B; Vanrenterghem Yves
The rate of gastric emptying determines the timing but not the extent of oral tacrolimus absorption: simultaneous measurement of drug exposure and gastric emptying by carbon-14-octanoic acid breath test in stable renal allograft recipients.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(12):1421-5.
-
2004: Kuypers Dirk R J; Vanrenterghem Yves
Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Clinical therapeutics 2004;26(11):1834-44.
-
2004: Kuypers D R J; Neumayer H H; Fritsche L; Budde K; Rodicio J L; Vanrenterghem Y;
Calcium channel blockade and preservation of renal graft function in cyclosporine-treated recipients: a prospective randomized placebo-controlled 2-year study.
Transplantation 2004;78(8):1204-11.
-
2004: Lemahieu W P D; Maes B D; Verbeke K; Vanrenterghem Y
CYP3A4 and P-glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(9):1514-22.
-
2004: Vlaminck Hans; Maes Bart; Evers Georges; Verbeke Geert; Lerut Evelyne; Van Damme Boudewijn; Vanrenterghem Yves
Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2004;4(9):1509-13.
-
2004: Vanrenterghem Yves
Anaemia after renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19 Suppl 5():V54-58.
-
2004: Bammens Bert; Evenepoel Pieter; Verbeke Kristin; Vanrenterghem Yves
Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):278-85.
-
2004: Cleemput Irina; Kesteloot Katrien; Moons Philip; Vanrenterghem Yves; Van Hooff Johannes P; Squifflet Jean-Paul; De Geest Sabina
The construct and concurrent validity of the EQ-5D in a renal transplant population.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2004;7(4):499-509.
-
2004: Vanrenterghem Yves; van Hooff Johannes P; Klinger Marian; Wlodarczyk Zbigniew; Squifflet Jean-Paul; Mourad Georges; Neuhaus Peter; Jurewicz Adam; Rostaing Lionel; Charpentier Bernard; Paczek Leszek; Kreis Henri; Chang Rene; Paul Leendert C; Grinyó Josep M; Short Colin
The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients.
Transplantation 2004;78(1):9-14.
-
2004: Lemahieu Wim P D; Maes Bart D; Verbeke Kirstin; Vanrenterghem Yves F Ch
Alterations of CYP3A4 and P-glycoprotein activity in vivo with time in renal graft recipients.
Kidney international 2004;66(1):433-40.
-
2004: Kuypers Dirk R; Claes Kathleen; Evenepoel Pieter; Maes Bart; Vanrenterghem Yves
A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1895-901.
-
2004: Tedesco-Silva Helio; Mourad Georges; Kahan Barry D; Boira Josep Grinyo; Weimar Willem; Mulgaonkar Shamkant; Nashan Björn; Madsen Soren; Charpentier Bernard; Pellet Pascale; Vanrenterghem Yves
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Transplantation 2004;77(12):1826-33.
-
2004: Kuypers Dirk R J; Claes Kathleen; Evenepoel Pieter; Maes Bart; Vanrenterghem Yves
Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
Clinical pharmacology and therapeutics 2004;75(5):434-47.
-
2004: Ghijsels Erik; Lerut Evelyn; Vanrenterghem Yves; Kuypers Dirk
Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;43(5):e34-8.
-
2004: Maes Bart D; Oyen Raymond; Claes Kathleen; Evenepoel Pieter; Kuypers Dirk; Vanwalleghem Johan; Van Damme Boudewijn; Vanrenterghem Yves F Ch
Mycophenolate mofetil in IgA nephropathy: results of a 3-year prospective placebo-controlled randomized study.
Kidney international 2004;65(5):1842-9.
-
2004: Evenepoel Pieter; Claes Kathleen; Kuypers Dirk; Maes Bart; Bammens Bert; Vanrenterghem Yves
Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(5):1281-7.
-
2004: Bechstein Wolf Otto; Malaise Jacques; Saudek Frantisek; Land Walter; Fernandez-Cruz Laureano; Margreiter Raimund; Nakache Richard; Secchi Antonio; Vanrenterghem Yves; Tydén Gunnar; Van Ophem Dominique; Berney Thierry; Boucek Peter; Landgraf Rüdiger; Kahl Andreas; Squifflet Jean-Paul;
Efficacy and safety of tacrolimus compared with cyclosporine microemulsion in primary simultaneous pancreas-kidney transplantation: 1-year results of a large multicenter trial.
Transplantation 2004;77(8):1221-8.
-
2004: Jadoul Michel; Vanrenterghem Yves; Foret Michel; Walker Rowan; Gray Stephen J
Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(4):898-903.
-
2004: Maes B D; Vanrenterghem Y F Ch
Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus.
Transplantation proceedings 2004;36(2 Suppl):40S-49S.
-
2004: Evenepoel Pieter; Zeegers Miranda; Segaert Siegfried; Claes Kathleen; Kuypers Dirk; Maes Bart; Flamen Patrick; Fransis Sabine; Vanrenterghem Yves
Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):469-73.
-
2004: Wauters Anne; Peetermans Willy E; Van den Brande Paul; De Moor Bart; Evenepoel Pieter; Keuleers Hilde; Kuypers Dirk; Stas Koen; Vanwalleghem Johan; Vanrenterghem Yves; Maes Bart D
The value of tuberculin skin testing in haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):433-8.
-
2004: Kuypers Dirk R J; Vanrenterghem Yves F C
Monoclonal antibodies in renal transplantation: old and new.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(2):297-300.
-
2004: Cleemput Irina; Kesteloot Katrien; Vanrenterghem Yves; De Geest Sabina
The economic implications of non-adherence after renal transplantation.
PharmacoEconomics 2004;22(18):1217-34.
-
2004: Kuypers Dirk R J; Claes Kathleen; Evenepoel Pieter; Maes Bart; Coosemans Willy; Pirenne Jacques; Vanrenterghem Yves
Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Clinical pharmacokinetics 2004;43(11):741-62.
-
2004: Naesens Maarten; Steels Paul; Verberckmoes René; Vanrenterghem Yves; Kuypers Dirk
Bartter's and Gitelman's syndromes: from gene to clinic.
Nephron. Physiology 2004;96(3):p65-78.
-
2003: Bammens Bert; Evenepoel Pieter; Verbeke Kristin; Vanrenterghem Yves
Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptoms.
Kidney international 2003;64(6):2238-43.
-
2003: Bammens Bert; Verbeke Kristin; Vanrenterghem Yves; Evenepoel Pieter
Evidence for impaired assimilation of protein in chronic renal failure.
Kidney international 2003;64(6):2196-203.
-
2003: Vandermarliere Annemie; Maes Bart; Vanrenterghem Yves
Recessive type of nephrogenic diabetes insipidus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;42(4):A41, E1.
-
2003: Kuypers D R J; Vanrenterghem Y; Squifflet J P; Mourad M; Abramowicz D; Oellerich M; Armstrong V; Shipkova M; Daems J
Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil.
Therapeutic drug monitoring 2003;25(5):609-22.
-
2003: Lemahieu W P D; Maes B D; Ghoos Y; Rutgeerts P; Verbeke K; Vanrenterghem Y
Measurement of hepatic and intestinal CYP3A4 and PGP activity by combined po + iv [14C]erythromycin breath and urine test.
American journal of physiology. Gastrointestinal and liver physiology 2003;285(3):G470-82.
-
2003: Moons Philip; Vanrenterghem Yves; Van Hooff Johannes P; Squifflet Jean-Paul; Margodt Dave; Mullens Monique; Thevissen Isabelle; De Geest Sabina
Health-related quality of life and symptom experience in tacrolimus-based regimens after renal transplantation: a multicentre study.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(9):653-64.
-
2003: Kuypers D R; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Long-term changes in mycophenolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients.
Journal of clinical pharmacology 2003;43(8):866-80.
-
2003: Kuypers D R J; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipients.
Therapeutic drug monitoring 2003;25(4):447-51.
-
2003: Van Audenhove A; Vandermarliere A; Lerut E; Lodewyckx T; Vanrenterghem Y; Maes B
beta 2 M-amyloidosis and gastrointestinal bleeding after renal transplantation.
Acta clinica Belgica 2003;58(4):248-50.
-
2003: Cleemput Irina; Kesteloot Katrien; De Geest Sabina; Dobbels Fabienne; Vanrenterghem Yves
Health professionals' perceptions of health status after renal transplantation: a comparison with transplantation candidates' expectations.
Transplantation 2003;76(1):176-82.
-
2003: Kuypers Dirk R J; Lerut Evelyne; Evenepoel Pieter; Maes Bart; Vanrenterghem Yves; Van Damme Boudewijn
C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome.
Transplantation 2003;76(1):102-8.
-
2003: Vanrenterghem Yves; Ponticelli Claudio; Morales José Maria; Abramowicz Daniel; Baboolal Keshwar; Eklund Björn; Kliem Volker; Legendre Christophe; Morais Sarmento Antonio Luis; Vincenti Flavio
Prevalence and management of anemia in renal transplant recipients: a European survey.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(7):835-45.
-
2003: van Hooff Johannes P; Squifflet Jean-Paul; Wlodarczyk Zbigniew; Vanrenterghem Yves; Paczek Leszek
A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients.
Transplantation 2003;75(12):1934-9.
-
2003: Kuypers D R J; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimus and early withdrawal of steroids in renal transplant recipients.
Clinical transplantation 2003;17(3):234-41.
-
2003: Maes Bart D; Evenepoel Pieter; Kuypers Dirk; Geypens Benny; Ghoos Yvo; Vanrenterghem Yves
Influence of SDZ RAD vs. MMF on gastric emptying in renal transplant recipients.
Clinical transplantation 2003;17(3):171-6.
-
2003: Jamar Sofie; Evenepoel Pieter; Kuypers Dirk; Maes Bart; Vanrenterghem Yves
A young patient with unexplained acute hepatorenal dysfunction.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(6):1220-2.
-
2003: Kuypers D R J; Herelixka A; Vanrenterghem Y;
Clinical use of rapamycin in renal allograft recipients identifies its relevant toxicity profile and raises unsolved questions: a single-center experience.
Transplantation proceedings 2003;35(3 Suppl):138S-142S.
-
2003: Vandermarliere A; Van Audenhove A; Peetermans W E; Vanrenterghem Y; Maes B
Mycobacterial infection after renal transplantation in a Western population.
Transplant infectious disease : an official journal of the Transplantation Society 2003;5(1):9-15.
-
2003: Vanrenterghem Yves; Claes Kathleen; Evenepoel Pieter; Kuypers Dirk; Maes Bart
Kidney transplantation with rabbit antithymocyte globulin and sirolimus monotherapy.
Lancet 2003;361(9361):969; author reply 969-70.
-
2003: Maes Bart D; Dalle Ignace; Geboes Karen; Oellerich Michael; Armstrong Victor W; Evenepoel Pieter; Geypens Benny; Kuypers Dirk; Shipkova Maria; Geboes Karel; Vanrenterghem Yves F Ch
Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.
Transplantation 2003;75(5):665-72.
-
2003: Wauters Anne; Dejagere Tom; Devriendt Koen; Vanrenterghem Yves; Maes Bart
Triangular face and vascular malformation. The links to renal failure.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(2):436-9.
-
2003: Maleux G; Messiaen T; Stockx L; Vanrenterghem Y; Wilms G
Transcatheter embolization of biopsy-related vascular injuries in renal allografts. Long-term technical, clinical and biochemical results.
Acta radiologica (Stockholm, Sweden : 1987) 2003;44(1):13-7.
-
2003: Evenepoel Pieter; Maes Bart; Wilmer Alexander; Nevens Frederik; Fevery Johan; Kuypers Dirk; Bammens Bert; Vanrenterghem Yves
Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters.
Blood purification 2003;21(3):244-52.
-
2002: Abramowicz Daniel; Manas Derek; Lao Mieczyslaw; Vanrenterghem Yves; Del Castillo Domingo; Wijngaard Peter; Fung Samson;
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen in stable kidney transplant recipients: a randomized, controlled study.
Transplantation 2002;74(12):1725-34.
-
2002: Claes Kathleen; Kuypers Dirk; Evenepoel Pieter; Maes Bart; Roskams Tania; Aerts Raymond; Pirenne Jacques; Mathieu Chantal; Vanrenterghem Yves
An uncommon tumor in a renal graft recipient: a diagnostic and therapeutic challenge.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;40(6):E21.
-
2002: Vanrenterghem Yves; Bárány Peter; Mann Johannes F E; Kerr Peter G; Wilson Janet; Baker Nigel F; Gray Stephen J;
Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
Kidney international 2002;62(6):2167-75.
-
2002: Maes Bart D; Lemahieu Wim; Kuypers Dirk; Evenepoel Pieter; Coosemans Willy; Pirenne Jacques; Vanrenterghem Yves F C
Differential effect of diarrhea on FK506 versus cyclosporine A trough levels and resultant prevention of allograft rejection in renal transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(10):989-92.
-
2002: Moons P; Vanrenterghem Y; van Hooff J P; Squifflet J P; Margodt D; Mullens M; Thevissen I; De Geest S
Steroids may compromise quality of life of renal transplant recipients on a tacrolimus-based regimen.
Transplantation proceedings 2002;34(5):1691-2.
-
2002: Kuypers D R J; Evenepoel P; Maes B D; Coosemans W; Pirenne J; Vanrenterghem Y F C h
Role of immunosuppressive drugs in the development of tissue-invasive cytomegalovirus infection in renal transplant recipients.
Transplantation proceedings 2002;34(4):1164-70.
-
2002: Maes Bart; Oellerich Michael; Ceuppens Jan L; Armstrong Victor W; Evenepoel Pieter; Kuypers Dirk; Messiaen Thierry; Shipkova Maria; Wieland Eberhard; Vanrenterghem Yves
A new acute inflammatory syndrome related to the introduction of mycophenolate mofetil in patients with Wegener's granulomatosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(5):923-6.
-
2002: Ricka Regula; Vanrenterghem Yves; Evers Georges C M
Adequate self-care of dialysed patients: a review of the literature.
International journal of nursing studies 2002;39(3):329-39.
-
2002: Evenepoel Pieter; Maes Bart; Vanwalleghem Johan; Kuypers Dirk; Messiaen Thierry; Vanrenterghem Yves
Regional citrate anticoagulation for hemodialysis using a conventional calcium-containing dialysate.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(2):315-23.
-
2002: Luyckx C; Van Damme B; Vanrenterghem Y; Maes B
Carcinoid tumor and membranous glomerulonephritis: coincidence or malignancy-associated glomerulonephritis?
Clinical nephrology 2002;57(1):80-4.
-
2002: Maes Bart D; Claes Kathleen; Coosemans Willy; Evenpoel Pieter; Kuypers Dirk; Pirenne Jacques; Vanrenterghem Yves
Cessation of steroids in stable renal transplant patients: the Leuven experience.
Clinical transplants 2002;():181-9.
-
2002: Vanrenterghem Yves
Prevalence and management of anaemia in transplant patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17 Suppl 1():47.
-
2001: Maes B D; Kuypers D; Messiaen T; Evenepoel P; Mathieu C; Coosemans W; Pirenne J; Vanrenterghem Y F
Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors.
Transplantation 2001;72(10):1655-61.
-
2001: Smet A D; Kuypers D; Evenepoel P; Maes B; Messiaen T; Van Damme B; Vanrenterghem Y
'Full house' positive immunohistochemical membranoproliferative glomerulonephritis in a patient with portosystemic shunt.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(11):2258-62.
-
2001: Vanrenterghem Y
Posttransplant cardiovascular risk: impact on long-term patient survival. Introduction.
Transplantation 2001;72(6 Suppl):S4.
-
2001: Maes B D; van Pelt J F; Peeters J C; Nevens F; Evenepoel P; Kuypers D; Messiaen T; Fevery J; Vanrenterghem Y F
The effect of mycophenolate mofetil on hepatitis B viral load in stable renal transplant recipients with chronic hepatitis B.
Transplantation 2001;72(6):1165-6.
-
2001: Geerinck K; Lukito G; Snoeck R; De Vos R; De Clercq E; Vanrenterghem Y; Degreef H; Maes B
A case of human orf in an immunocompromised patient treated successfully with cidofovir cream.
Journal of medical virology 2001;64(4):543-9.
-
2001: Squifflet J P; Bäckman L; Claesson K; Dietl K H; Ekberg H; Forsythe J L; Kunzendorf U; Heemann U; Land W; Morales J M; Mühlbacher F; Talbot D; Taube D; Tyden G; van Hooff J; Schleibner S; Vanrenterghem Y;
Dose optimization of mycophenolate mofetil when administered with a low dose of tacrolimus in cadaveric renal transplant recipients.
Transplantation 2001;72(1):63-9.
-
2001: Dobbels F; De Geest S; Cleemput I; Fischler B; Kesteloot K; Vanhaecke J; Vanrenterghem Y
Psychosocial and behavioral selection criteria for solid organ transplantation.
Progress in transplantation (Aliso Viejo, Calif.) 2001;11(2):121-30; quiz 131-2.
-
2001: Coosemans W; Baert L; Kuypers D; Maes B; Messiaen T; Vanrenterghem Y; Pirenne J
Renal transplantation onto abnormal urinary tract: ileal conduit urinary diversion.
Transplantation proceedings 2001;33(4):2493-4.
-
2001: Hendrickx L; Kuypers D; Evenepoel P; Maes B; Messiaen T; Vanrenterghem Y
A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters.
The International journal of artificial organs 2001;24(4):208-11.
-
2001: Ricka R; Evers G C; Vanrenterghem Y
[Self management promotes well-being in dialysis patients]
Krankenpflege. Soins infirmiers 2001;94(8):36.
-
2001: Evenepoel P; Kuypers D; Maes B; Messiaen T; Vanrenterghem Y
Persistent hyperparathyroidism after kidney transplantation requiring parathyroidectomy.
Acta oto-rhino-laryngologica Belgica 2001;55(2):177-86.
-
2000: Fritsche L; Vanrenterghem Y; Nordal K P; Grinyo J M; Moreso F; Budde K; Kunz R; Meyerrose B; Neumayer H H
Practice variations in the evaluation of adult candidates for cadaveric kidney transplantation: a survey of the European Transplant Centers.
Transplantation 2000;70(10):1492-7.
-
2000: Messiaen T; Van Damme B; Kuypers D; Maes B; Vanrenterghem Y
Crescentic glomerulonephritis complicating the course of a hypocomplementemic urticarial vasculitis.
Clinical nephrology 2000;54(5):409-12.
-
2000: Vanrenterghem Y; Lebranchu Y; Hené R; Oppenheimer F; Ekberg H
Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.
Transplantation 2000;70(9):1352-9.
-
2000: Vanwalleghem J; Maes B; Kuypers D; Messiaen T; Evenepoel P; Vanrenterghem Y
Dialysis techniques in the critically-ill patient.
Acta clinica Belgica 2000;55(5):237-43.
-
2000: Maes B; Van Mieghem A; Messiaen T; Kuypers D; Van Damme B; Vanrenterghem Y
Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2000;36(3):E16.
-
2000: Vanrenterghem Y
Cautious approach to use of non-heart-beating donors.
Lancet 2000;356(9229):528.
-
2000: Schepens D; Verswijvel G; Kuypers D; Vanrenterghem Y
Images in Nephrology. Renal cortical nephrocalcinosis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2000;15(7):1080-2.
-
2000: Cohen B; Persijn G G; Vanrenterghem Y
Commerce in transplantation: how does it affect European legislation?
Clinical transplantation 2000;14(1):28-31.
-
2000: Fritsche L; Nordal K P; Vanrenterghem Y; Grinyo J M; Moreso F; Budde K; Neumayer H H
Different diagnostic approaches to adult candidates for cadaveric kidney transplantation in Europe.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S263-6.
-
1999: Vanrenterghem Y
Strategies to reduce or replace steroid dosing.
Transplantation proceedings 1999;31(8A):7S-10S.
-
1999: Vanrenterghem Y F
Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
Current opinion in nephrology and hypertension 1999;8(6):669-74.
-
1999: Maes B D; Vanwalleghem J; Kuypers D; Ghoos Y; Rutgeerts P J; Vanrenterghem Y F
Differences in gastric motor activity in renal transplant recipients treated with FK-506 versus cyclosporine.
Transplantation 1999;68(10):1482-5.
-
1999: Vanrenterghem Y
Vascular rejection with tacrolimus and potential long-term graft outcome.
Transplantation proceedings 1999;31(7A):86S-87S.
-
1999: Kuypers D R; Vanrenterghem Y F
Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(10):2304-8.
-
1999: Kuypers D; Vanwalleghem J; Maes B; Messiaen T; Vanrenterghem Y; Peetermans W E
Cefazolin serum concentrations with fixed intravenous dosing in patients on chronic hemodialysis treatment.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(8):2050-1.
-
1999: Coosemans W; Rega F; Roels L; Peeters J; Donck J; Vanwalleghem J; Maes B; Vanrenterghem Y; Pirenne J
Impact of early vesico ureteral reflux on the transplanted kidney.
Transplantation proceedings 1999;31(1-2):362-4.
-
1999: Undre N A; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales J M; Andrés A; Schäfer A; Stevenson P
Low systemic exposure to tacrolimus correlates with acute rejection.
Transplantation proceedings 1999;31(1-2):296-8.
-
1999: Maes B; Vanwalleghem J; Kuypers D; Van Damme B; Waer M; Vanrenterghem Y
IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;33(2):E3.
-
1998: Roels L; Coosemans W; Donck J; Maes B; Peeters J; Vanwalleghem J; Pirenne J; Vanrenterghem Y
Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation.
Transplantation 1998;66(12):1660-4.
-
1998: Vanwalleghem J; Zachée P; Kuypers D; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Renal transplantation for end-stage renal disease due to paroxysmal nocturnal haemoglobinuria.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(12):3250-2.
-
1998: Kuypers D R; Vanrenterghem Y
Prophylaxis of cytomegalovirus infection in renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(12):3012-6.
-
1998: Cohen B; McGrath S M; De Meester J; Vanrenterghem Y; Persijn G G
Trends in organ donation.
Clinical transplantation 1998;12(6):525-9.
-
1998: De Meester J; Persijn G G; Wujciak T; Opelz G; Vanrenterghem Y
The new Eurotransplant Kidney Allocation System: report one year after implementation. Eurotransplant International Foundation.
Transplantation 1998;66(9):1154-9.
-
1998: Vanrenterghem Y
Tacrolimus (FK 506) in kidney transplantation.
Transplantation proceedings 1998;30(5):2171-3.
-
1998: Undre N A; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales J M; Andrés A; Schäfer A; Stevenson P
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation.
Transplantation proceedings 1998;30(4):1299-302.
-
1998: Claesson K; Mayer A D; Squifflet J P; Grabensee B; Eigler F W; Behrend M; Vanrenterghem Y; van Hooff J; Morales J M; Johnson R W; Buchholz B; Land W; Forsythe J L; Neumayer H H; Ericzon B G; Mühlbacher F
Lipoprotein patterns in renal transplant patients: a comparison between FK 506 and cyclosporine A patients.
Transplantation proceedings 1998;30(4):1292-4.
-
1998: Vanrenterghem Y; Squifflet J P; Forsythe J; Heeman U; Bäckman L; Taube D; Morales J M; Ekberg H; van Hooff J; Zanker B; Dietl K H; Talbot D; Hauser I; Tydén G; Claesson K; Mühlbacher F
Co-administration of tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients.
Transplantation proceedings 1998;30(4):1290-1.
-
1998: Vanrenterghem Y
Role of acute rejection in chronic rejection.
Transplantation proceedings 1998;30(4):1210-1.
-
1998: Remes J; Peeters J; Coosemans W; Donck J; Geuens M; Vlaminck H; Vanrenterghem Y
Five years of surgical experience with peritoneal dialysis.
Acta chirurgica Belgica 1998;98(2):66-70.
-
1998: Vanwalleghem J; Maes B; Van Damme B; Verberckmoes R; Vanrenterghem Y
Steroids for deep-infection-associated glomerulonephritis: a two-edged sword.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13(3):773-5.
-
1998: Coosemans W; Peeters J; Aerts R; Christiaens M R; Donck J; Vanwalleghem J; Verberckmoes R; Waer M; Pirenne J; Vanrenterghem Y
Complications and outcome of combined kidney-pancreas transplantation for end-stage diabetic nephropathy: a retrospective single-center analysis. Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1998;30(2):274-5.
-
1998: Sheng L; Widyastuti A; Kosala H; Donck J; Vanrenterghem Y; Setijoso E; Soumillion A; Verslype C; Schelstraete R; Emonds M P; Hess G; Yap S H
High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(2):218-23.
-
1998: Vanrenterghem Y
The use of mycophenolate mofetil (Cellcept) in renal transplantation.
Contributions to nephrology 1998;124():64-9; discussion 69-75.
-
1998: Vervloessem I; Oyen R; Vanrenterghem Y; Van Poppel H; Van Hover P; Debakker G; Baert A L
Transitional cell carcinoma in a renal allograft.
European radiology 1998;8(6):936-8.
-
1998: Vanrenterghem Y; Vanwalleghem J
Benefits and concerns of treating pre-dialysis and renal transplant patients with recombinant human erythropoietin.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1998;13 Suppl 2():13-5.
-
1997: Vanrenterghem Y F
Impact of new immunosuppressive agents on late graft outcome.
Kidney international. Supplement 1997;63():S81-3.
-
1997: Mayer A D; Dmitrewski J; Squifflet J P; Besse T; Grabensee B; Klein B; Eigler F W; Heemann U; Pichlmayr R; Behrend M; Vanrenterghem Y; Donck J; van Hooff J; Christiaans M; Morales J M; Andres A; Johnson R W; Short C; Buchholz B; Rehmert N; Land W; Schleibner S; Forsythe J L; Talbot D; Pohanka E
Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.
Transplantation 1997;64(3):436-43.
-
1997: Vanwalleghem J; Coosemans W; Raat H; Waer M; Vanrenterghem Y
Peritransplant lymphocele causing arterial hypertension by a Page kidney phenomenon. Leuven Collaborative Group for Transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(4):823-4.
-
1997: Roels L; Deschoolmeester G; Vanrenterghem Y
A profile of people objecting to organ donation in a country with a presumed consent law: data from the Belgian National Registry.
Transplantation proceedings 1997;29(1-2):1473-5.
-
1997: Vanrenterghem Y
The use of Mycophenolate Mofetil (Cellcept) in renal transplantation.
Nephron 1997;76(4):392-9.
-
1997: Vanrenterghem Y
Lymphoproliferative disorders in organ transplant recipients.
European radiology 1997;7(5):665-7.
-
1996: Holvoet P; Donck J; Landeloos M; Brouwers E; Luijtens K; Arnout J; Lesaffre E; Vanrenterghem Y; Collen D
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
Thrombosis and haemostasis 1996;76(5):663-9.
-
1996: Verberckmoes R; Verbeken E; Verschakelen J; Vanrenterghem Y
BOOP (bronchiolitis obliterans organizing pneumonia) after renal transplantation.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(9):1862-3.
-
1996: Vanrenterghem Y; Peeters J
Chronic renal allograft function under cyclosporin treatment. Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1996;28(4):2097-9.
-
1996: Roels L; Peeters J; Vanrenterghem Y
Delayed graft function as principal correlate of kidney allograft outcome in a single-center multivariate analysis.
Transplantation proceedings 1996;28(1):272-4.
-
1996: Smits J M; De Meester J; Persijn G G; Claas F H; Vanrenterghem Y
Long-term results of solid organ transplantation. Report from the Eurotransplant International Foundation.
Clinical transplants 1996;():109-27.
-
1996: Stas K J; Louwagie P G; Van Damme B J; Coosemans W; Waer M; Vanrenterghem Y F
Isolated zygomycosis in a bought living unrelated kidney transplant.
Transplant international : official journal of the European Society for Organ Transplantation 1996;9(6):600-2.
-
1996: Emonds M P; Mytilineos Y; Scherer S; Waer M; Vanrenterghem Y; Opelz G; Dendievel J; Vermylen C
A single center evaluation of the Collaborative Transplant Study (CTS) DNA project.
Transplant international : official journal of the European Society for Organ Transplantation 1996;9(5):468-75.
-
1995: Peeters J; Roels L; Vanrenterghem Y
Chronic renal allograft failure: clinical overview. The Leuven Collaborative Group for Transplantation.
Kidney international. Supplement 1995;52():S97-101.
-
1995: Leenaerts P L; Hall B M; Van Damme B J; Daha M R; Vanrenterghem Y F
Active Heymann nephritis in complement component C6 deficient rats.
Kidney international 1995;47(6):1604-14.
-
1995: Roels L; Coosemans W; Christiaens M R; Waer M; Vanrenterghem Y
The relative impact of legislative incentives on multi-organ donation rates in Europe.
Transplantation proceedings 1995;27(1):795-6.
-
1995: De Geest S; Borgermans L; Gemoets H; Abraham I; Vlaminck H; Evers G; Vanrenterghem Y
Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients.
Transplantation 1995;59(3):340-7.
-
1995: Peeters J; Christiaens M R; Coosemans W; Donck J; Roels L; Verberckmoes R; Waer M; Vanrenterghem Y
A single-center multiple regression analysis of covariates associated with long-term cadaveric renal allograft survival: further improvement of long-term results with CsA.
Clinical transplants 1995;():255-60.
-
1995: Vanrenterghem Y F
Acute rejection and renal allograft outcome.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1995;10 Suppl 1():29-31.
-
1994: Vanrenterghem Y; Peeters J
Impact of cyclosporine on chronic rejection and graft vasculopathy.
Transplantation proceedings 1994;26(5):2560-3.
-
1994: Leenaerts P L; Stad R K; Hall B M; Van Damme B J; Vanrenterghem Y; Daha M R
Hereditary C6 deficiency in a strain of PVG/c rats.
Clinical and experimental immunology 1994;97(3):478-82.
-
1994: Donck J B; Segaert M F; Vanrenterghem Y F
Fluoroquinolones and Achilles tendinopathy in renal transplant recipients.
Transplantation 1994;58(6):736-7.
-
1994: Henckes M; Roskams T; Vanneste S; Van Damme B; Vanrenterghem Y
Polyarteritis nodosa type vasculitis in a patient with familial Mediterranean fever treated with cyclosporin A.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7(4):292-6.
-
1994: Verresen L; Fink E; Lemke H D; Vanrenterghem Y
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes.
Kidney international 1994;45(5):1497-503.
-
1994: Laurens W E; Vanrenterghem Y F; Steels P S; Van Damme B J
A new single nephron model of focal and segmental glomerulosclerosis in the Munich-Wistar rat.
Kidney international 1994;45(1):143-9.
-
1994: Roels L; Waer M; Coosemans W; Christiaens M R; Vanrenterghem Y
The influence of donor age on initial and long-term renal allograft outcome. Leuven Collaborative Group for Transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S303-5.
-
1994: Vanrenterghem Y; Waer M; Roels L; Coosemans W; Christaens M R; Opelz G
A prospective, randomized trial of pretransplant blood transfusions in cadaver kidney transplant candidates. Leuven Collaborative Group for Transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1994;7 Suppl 1():S243-6.
-
1993: Michielsen P; Vanrenterghem Y
Use of NSAIDs in kidney transplantation.
Transplantation proceedings 1993;25(2):2087-8.
-
1992: Emonds M P; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
Transplantation proceedings 1992;24(6):2502-3.
-
1992: Roels L; Vanrenterghem Y; Waer M; Dendievel J; Emonds M P; Christiaens R; Gruwez J; Michielsen P
Single center experience with the CTS-HIT allocation system for highly immunized patients. The Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1992;24(6):2492-3.
-
1992: Staessen J A; Lauwerys R R; Buchet J P; Bulpitt C J; Rondia D; Vanrenterghem Y; Amery A
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.
The New England journal of medicine 1992;327(3):151-6.
-
1992: Vanrenterghem Y; Waer M; Christiaens M R; Michielsen P
Bilateral nephrectomy of the native kidneys reduces the incidence of arterial hypertension and erythrocytosis in kidney graft recipients treated with cyclosporin. Leuven Collaborative Group for Transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1992;5 Suppl 1():S35-7.
-
1991: Verresen L; Waer M; Vanrenterghem Y; Michielsen P
Anaphylactoid reactions, haemodialysis, and ACE inhibitors.
Lancet 1991;337(8752):1294.
-
1991: Roels L; Vanrenterghem Y; Waer M; Christiaens M R; Gruwez J; Michielsen P
Three years of experience with a 'presumed consent' legislation in Belgium: its impact on multi-organ donation in comparison with other European countries. The Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1991;23(1 Pt 2):903-4.
-
1991: Vanrenterghem Y; Waer M; Christiaens R; Roels L; Gruwez J; Michielsen P
Long-term results after cadaver kidney transplantation have also improved over the last two decades. The Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1991;23(1 Pt 2):1265-6.
-
1990: Verresen L; Waer M; Vanrenterghem Y; Michielsen P
Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis.
Lancet 1990;336(8727):1360-2.
-
1990: Rigauts H; Marchal G; Grieten M; Van Damme B; Vanrenterghem Y; Waer M; Verbrugge H
Duplex Doppler evaluation of renal allograft dysfunction: Doppler signal quantitation and pathologic correlation.
Journal belge de radiologie 1990;73(6):475-83.
-
1990: Roels L; Vanrenterghem Y; Waer M; Gruwez J; Michielsen P
Effect of a presumed consent law on organ retrieval in Belgium.
Transplantation proceedings 1990;22(4):2078-9.
-
1990: Vanrenterghem Y; Waer M; Roels L; Christiaens R; Gruwez J; Michielsen P
Long-term prognosis of cadaver renal allografts transplanted with cyclosporine as basic immunosuppression. The Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1990;22(4):1691-2.
-
1990: Vandepitte K; Vanrenterghem Y; Michielsen P
Azathioprine hypersensitivity in a renal transplant recipient.
Transplant international : official journal of the European Society for Organ Transplantation 1990;3(1):47-8.
-
1990: Roels L; Vanrenterghem Y; Waer M; Christiaens M; Gruwez J; Michielsen P
The aging kidney donor: another answer to organ shortage? The Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1990;22(2):368-70.
-
1989: Vanrenterghem Y; Roels L; Vandermeersch E; Christiaens R; Gruwez J; Michielsen P
University of Wisconsin preservation solute and bradyarrhythmia.
Lancet 1989;2(8665):745.
-
1989: Marchal G; Rigauts H; Van Damme B; Vanrenterghem Y; Waer M; Verbrugge H; Baert A; Michielsen P
Duplex Doppler evaluation of renal allograft dysfunction.
Transplantation proceedings 1989;21(1 Pt 2):1893-4.
-
1989: Waer M; Leenaerts P; Vanrenterghem Y; Roels L; van der Schueren E; Vandeputte M; Michielsen P
Factors determining the success rate of total lymphoid irradiation in clinical kidney transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1796-7.
-
1989: Vanrenterghem Y; Waer M; Roels L; Michielsen P
Optimal cyclosporin levels during the first month after cadaveric kidney transplantation. Leuven Collaborative Group for Transplantation.
Transplantation proceedings 1989;21(1 Pt 2):1467-8.
-
1988: Waer M; Vanrenterghem Y; Roels L; Verberckmoes R; Hauglustaine D; van der Schueren E; Lerut T; Gruwez J; Bouillon R; Vandeputte M
Renal cadaveric transplantation in diabetics using total lymphoid irradiation or cyclosporin A. A controlled randomized study. Leuven Collaborative Transplantation Group.
Transplant international : official journal of the European Society for Organ Transplantation 1988;1(2):64-8.
-
1988: Vanrenterghem Y; Waer M; Roels L; Lerut T; Gruwez J; Vandeputte M; Michielsen P
Shortage of kidneys, a solvable problem? The Leuven experience. Leuven Collaborative Group for Transplantation.
Clinical transplants 1988;():91-7.
-
1988: Verresen L; Vanrenterghem Y; Waer M; Hauglustaine D; Michielsen P
Corticosteroid withdrawal syndrome in dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1988;3(4):476-7.
-
1987: Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
Is cyclosporine-associated nephrotoxicity progressive?
Transplantation proceedings 1987;19(5):4031-2.
-
1987: Vanrenterghem Y; Roels L; Lerut T; Waer M; Gruwez J; Michielsen P
Long-term prognosis after cadaveric kidney transplantation.
Transplantation proceedings 1987;19(5):3762-4.
-
1987: Waer M; Vanrenterghem Y; Roels L; Ang K K; Bouillon R; Lerut T; Gruwez J; van der Schueren E; Vandeputte M; Michielsen P
Immunological and clinical observations in diabetic kidney graft recipients pretreated with total-lymphoid irradiation.
Transplantation 1987;43(3):371-9.
-
1987: Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
Transplantation proceedings 1987;19(1 Pt 1):685-6.
-
1987: Vanrenterghem Y; Waer M; Roels L; Michielsen P
A controlled trial comparing pretransplant total lymphoid irradiation versus posttransplant cyclosporine in type I diabetic cadaveric kidney graft recipients: short-term results.
Transplantation proceedings 1987;19(1 Pt 2):1542-3.
-
1985: Waer M; Vanrenterghem Y; Roels L; Ang K K; Bouillon R; Lerut T; Gruwez J; Michielsen P; Van der Schueren E; Vandeputte M
Total lymphoid irradiation in renal cadaveric transplantation in diabetics.
Lancet 1985;2(8468):1354.
-
1985: Vanrenterghem Y; Roels L; Lerut T; Gruwez J; Michielsen P; Gresele P; Deckmyn H; Colucci M; Arnout J; Vermylen J
Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients.
Lancet 1985;1(8436):999-1002.
-
1983: Vanrenterghem Y; Vandeputte I; Lerut T; Roels L; Gruwez J; Michielsen P
Importance of HLA-DR matching in polytransfused cadaveric kidney transplant recipients. A prospective one-center study.
Transplantation 1983;36(4):384-7.
-
1983: Vanrenterghem Y; Waer M; Ang K K; Lerut T; Bouillon R; Vandeputte I; Vandeputte M; van der Schueren E; Gruwez J; Michielsen P
Renal cadaveric transplantation after total lymphoid irradiation in patients with diabetes.
Kidney international. Supplement 1983;(14):S-69-73.
-
1983: Vanrenterghem Y; Vandeputte I; Lerut T; Gruwez J; Vandeputte M; Michielsen P
HLA-A-matched and HLA-B-matched blood transfusions do not improve kidney allograft survival.
The New England journal of medicine 1983;308(18):1102.
Sign-in to see more
